FDA / Associate Director for Policy, Center for Biologics Evaluation and Research (CBER)
Diane Maloney is the Associate Director for Policy in the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA). She oversees policy and regulations development related to biological products for CBER and works closely with the other centers and the Commissioner’s office on cross-cutting policy matters. She also chairs CBER’s Patient Engagement Workgroup. Prior to coming to CBER, she worked in FDA’s Office of the Chief Counsel.